P-ISSN 0002-4678
E-ISSN 2162-4151
Vol. 83, Issue 1, 2020January 17, 2020 EDT
BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE
BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE
Lars Noah,
U.S. Food and Drug Administration“off-label” usesapproved therapeutic productsFirst Amendmentcommercial free speech principlesU.S. Supreme Courtbrand-name competitors
Articles in Vol. 83, Issue 1, 2020
Vol. 83, Issue 1, 2020
- APPLYING THE FIRST AMENDMENT TO THE INTERNAL REVENUE CODE: MINNESOTA VOTERS ALLIANCE AND THE TAX LAW’S REGULATION OF NONPROFIT ORGANIZATIONS’ POLITICAL SPEECHEdward A. Zelinsky
- THE PERENNIAL QUEST FOR BOARD INDEPENDENCE: ARTIFICIAL INTELLIGENCE TO THE RESCUE?Akshaya Kamalnath
- UNJUST TIMING LIMITATIONS IN GENETIC MALPRACTICE CASESGary MarchantBonnie LeRoyLauren ClatchEllen Wright Clayton
- A MEDICAL/LEGAL PERSPECTIVE ON STEM CELL THERAPY: A SCIENTIFIC BREAKTHROUGH OR SNAKE OIL?Samuel D. Hodge Jr.
- THE MYTH OF THE COUNTRY LAWYERJudy M. CornettHeather H. Bosau
- THE KING IN HIS COURT: CHIEF JUSTICE JOHN ROBERTS AT THE CENTERBenjamin Pomerance
- THE SANCTUARY OF PROSECUTORIAL NULLIFICATIONZohra Ahmed
- BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASELars Noah
- FANNING THE FLAMES: GASLIGHTING AS A TACTIC OF PSYCHOLOGICAL ABUSE AND CRIMINAL PROSECUTIONDelaney Rives Knapp
Lars Noah, BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE, 83 Albany Law Review (2020).